COMMUNIQUÉS West-GlobeNewswire

MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million
03/04/2019
TORONTO, April 03, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
Dr. Charles Brenner, Discoverer of Nutrient Nicotinamide Riboside as a Vitamin, Announced as Speaker at Upgrade XP’s Sixth Annual Biohacking Conference
03/04/2019
World’s leading expert on NAD metabolism to speak at #UpgradeXP2019 LOS ANGELES, April 03, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today its Chief Scientific Advisor, Dr. Charles Brenner, the [...]
Achillion Announces Enrollment Milestone in Phase 2 Trials for C3 Glomerulopathy
03/04/2019
- Enrolled 23 patients in ACH-4471 Phase 2 C3G six and 12-month clinical trials - - Targeting end-of-Phase 2 meeting with FDA in fourth quarter of 2019 - BLUE BELL, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Achillion [...]
Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2019
03/04/2019
Company Release no. 06/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 April 2019 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2019 Summary: At Veloxis Pharmaceuticals A/S’ Annual General [...]
Short report of the status of the review in Oasmia
03/04/2019
Two weeks ago, March 19 th , the Extra General Meeting in Oasmia elected a new Board on the initiative of the main owner Arwidsro. The new Board has since then taken control over the Company and started implementing new [...]
Interim report September 1, 2018 – February 28, 2019
03/04/2019
Company announcement No. 05/2019 Report attached For further information, please contact: Head of Investor Relations Martin Riise Tel.: +45 5339 2250 Investor Relations Officer Annika Stern Tel.: +45 2399 2382 Head of [...]
Dovitinib regulatory strategy confirmed and new combination biomarker DRP PD1/PD-L1 + dovitinib developed. Oncology Venture engages in partnering activities with Destum Partners
03/04/2019
Press release Hoersholm, Denmark, April 3, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today announces that the company has confirmed its regulatory strategy of submission of a new drug application [...]
Sandoz resubmits biosimilar pegfilgrastim application to US FDA
03/04/2019
Sandoz pursues US approval for biosimilar pegfilgrastim, a long-acting version of supportive oncology medicine filgrastim Pegfilgrastim is used to reduce the incidence of neutropenia, one of the most serious side [...]
Santhera Provides Update on Near-term Corporate Financing Initiatives
03/04/2019
Pratteln, Switzerland, April 3, 2019 - Santhera Pharmaceuticals (SIX: SANN) announces that it has entered into a CHF 15.0 million credit line facility and is providing an update on ongoing corporate financing [...]
ADMA Receives Department of Health and Human Services U.S. License
03/04/2019
RAMSEY, N.J. and BOCA RATON, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]
Ken Ludlum Appointed to IRIDEX Board of Directors
03/04/2019
MOUNTAIN VIEW, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]
Veloxis Increases Share Capital in Connection with Exercise of Warrants
02/04/2019
Company Release no. 05/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 02 April 2019 Veloxis Increases Share Capital in Connection with Exercise of Warrants Veloxis Pharmaceuticals A/S announces that the Company's [...]
BODY GLOBE BODY ARMOR® COMPLETES LEVEL II BALLISTICS TEST HOVERINK BIOTECHNOLOGIES ANNOUNCES THEY ARE NOW TAKING PRE-SALE ORDERS
02/04/2019
LOS ANGELES, CA, April 02, 2019 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today that on February 28, 2019, HP White concluded its level II ballistics test for the U.S. Patent pending: BODY GLOBE BODY [...]
MacroGenics to Participate in Upcoming Investor Conferences
02/04/2019
ROCKVILLE, MD, April 02, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Corium Appoints Perry Sternberg as Chief Executive Officer
02/04/2019
Former Shire Executive Brings Strong Track Record in Commercializing CNS Products MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Corium, Inc. announced today that its Board of Directors has named Perry Sternberg [...]
Natus Announces Sale of Medix Business
02/04/2019
“Local Management to acquire the stock of Natus' Argentinian subsidiary” PLEASANTON, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) (the “Company” or “Natus”), a leading provider of [...]
Geron to Present at Needham Healthcare Conference
02/04/2019
MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a company overview at [...]
Voyager Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
02/04/2019
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today [...]
Clearside Biomedical to Present at the 18th Annual Needham Healthcare Conference
02/04/2019
ALPHARETTA, Ga., April 02, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Pages